• Accueil >
  • Publications >
  • Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

1 janv. 2020The Lancet Oncology

DOI : 10.1016/s1470-2045(19)30693-x

Auteurs

Birgit Geoerger, C Michel Zwaan, Lynley V Marshall, Jean Michon, Franck Bourdeaut, Michela Casanova, Nadège Corradini, Gianluca Rossato, Mufiza Farid-Kapadia, Colby S Shemesh, Katherine E Hutchinson, Francis Donaldson, Minlei Liao, Hubert Caron, Tanya Trippett